TG Therapeutics Inc (TGTX) (Q3 2026) Earnings Call Highlights: Revenue Jumps 61% as Guidance ...
TG Therapeutics Inc (TGTX) posted $260 million in quarterly revenue, notched its 14th straight quarter of BRIUMVI growth, and raised full-year 2026 guidance to roughly $1 billion. Related Stocks: TGTX ,